by IgNS | Mar 27, 2020 | ItsMyTurn, Latest News
During this unprecedented time of fear and uncertainty, we witness daily the incredible sacrifices of healthcare professionals, EMS, military, law enforcement, and others working tirelessly to keep patients healthy and save lives. We have witnessed people coming...
by IgNS | Mar 20, 2020 | Latest News
IgNS places the utmost importance on maintaining the health and safety of patients and healthcare providers during this COVID-19 global pandemic. IgNS has compiled relevant guidance to support clinicians and patients through the complexities of managing Ig patients...
by IgNS | Mar 18, 2020 | Latest News
Coronavirus vaccine trial administers first doses to participants A Phase 1 clinical trial evaluating an investigational vaccine designed to protect against coronavirus disease 2019 (COVID-19) has begun at Kaiser Permanente Washington Health Research Institute...
by IgNS | Mar 17, 2020 | Latest News
Dear Colleagues, IgNS is closely following the developments regarding the COVID-19 pandemic. This is a rapidly evolving situation, with information and guidance updated on an ongoing basis to reflect the most recent recommendations. Please check for updates from the...
by IgNS | Mar 14, 2020 | Latest News
COVID-19 Update IgNS thanks all healthcare professionals and service providers, first responders, government agencies, and the healthcare industry who are working tirelessly in the face of the COVID-19 pandemic. Roche receives emergency approval for COVID-19...
by IgNS | Feb 27, 2020 | Latest News
Novel Coronavirus (COVID-19 or SARS-CoV-2) and Plasma Safety IgNS Statement Regarding the Novel Coronavirus (COVID-19 or SARS-CoV-2) The recent outbreak of the 2019 Novel Coronavirus (COVID-19 or SARS-CoV-2) has raised awareness around the safety of plasma...
